Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7595304

Concept 2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-18,000,000 JPY
1,664,000,000 JPY
1,728,000,000 JPY
-169,000,000 JPY
124,000,000 JPY
1,833,000,000 JPY
-2,000,000 JPY
1,348,000,000 JPY
-160,000,000 JPY
1,247,000,000 JPY
103,000,000 JPY
1,188,000,000 JPY
Non-operating income
Non-operating income
212,000,000 JPY
234,000,000 JPY
Non-operating expenses
Non-operating expenses
71,000,000 JPY
92,000,000 JPY
Ordinary profit (loss)
1,805,000,000 JPY
1,329,000,000 JPY
Profit (loss) before income taxes
1,805,000,000 JPY
1,329,000,000 JPY
Income taxes - current
199,000,000 JPY
165,000,000 JPY
Income taxes - deferred
283,000,000 JPY
65,000,000 JPY
Profit (loss)
1,323,000,000 JPY
1,098,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.